Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 12:53 pm Unchanged | 2026-06-30 | 13G | TELA BIO INC TELA | SilverArc Capital Management, LLC | 2,137,201 4.800% | 0 (Unchanged) | Filing History |
| 2026-08-14 12:48 pm Unchanged | 2026-06-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SilverArc Capital Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-08-14 12:46 pm Unchanged | 2026-06-30 | 13G | ELUTIA INC ELUT | SilverArc Capital Management, LLC | 2,192,980 4.900% | 0 (Unchanged) | Filing History |
| 2026-08-14 12:11 pm Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | SilverArc Capital Management, LLC | 851,285 9.990% | 851,285 (New Position) | Filing History |
| 2026-08-11 10:44 am Sale | 2026-06-30 | 13G | TELA BIO INC TELA | SilverArc Capital Management, LLC | 2,137,201 4.800% | -928,448 (-30.29%) | Filing History |
| 2026-08-11 10:42 am Sale | 2026-06-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SilverArc Capital Management, LLC | 0 0.000% | -2,876,407 (Position Closed) | Filing History |
| 2026-08-11 10:37 am Purchase | 2026-06-30 | 13G | ELUTIA INC ELUT | SilverArc Capital Management, LLC | 2,192,980 4.900% | 410,709 (+23.04%) | Filing History |
| 2026-05-13 4:42 pm Unchanged | 2026-03-31 | 13G | NEXTCURE INC NXTC | SilverArc Capital Management, LLC | 176,057 4.900% | 0 (Unchanged) | Filing History |
| 2026-05-13 4:40 pm Purchase | 2026-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SilverArc Capital Management, LLC | 2,876,407 5.600% | 2,876,407 (New Position) | Filing History |
| 2026-05-13 4:35 pm Purchase | 2026-03-31 | 13G | HELIX ACQUISITION CORP. III US HLXC | SilverArc Capital Management, LLC | 1,208,986 6.800% | 1,208,986 (New Position) | Filing History |
| 2026-05-13 4:20 pm Sale | 2026-03-31 | 13G | FRACTYL HEALTH INC GUTS | SilverArc Capital Management, LLC | 3,606,386 2.300% | -6,993,614 (-65.98%) | Filing History |
| 2026-02-12 12:05 pm Purchase | 2025-12-31 | 13G | NEXTCURE INC NXTC | SilverArc Capital Management, LLC | 176,057 5.020% | 176,057 (New Position) | Filing History |
| 2026-02-10 11:36 am Sale | 2025-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | SilverArc Capital Management, LLC | 524,436 2.830% | -196,486 (-27.25%) | Filing History |
| 2025-11-14 1:11 pm Purchase | 2025-09-30 | 13G | IBIO INC PAR $0.001 IBIO | SilverArc Capital Management, LLC | 2,181,422 9.990% | 2,181,422 (New Position) | Filing History |
| 2025-11-14 12:47 pm Purchase | 2025-09-30 | 13G | FRACTYL HEALTH INC GUTS | SilverArc Capital Management, LLC | 10,600,000 8.020% | 10,600,000 (New Position) | Filing History |
| 2025-11-14 12:39 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | SilverArc Capital Management, LLC | 720,922 5.480% | 720,922 (New Position) | Filing History |
| 2025-02-12 3:54 pm Purchase | 2024-12-31 | 13G | TELA BIO INC TELA | SilverArc Capital Management, LLC | 3,065,649 7.800% | 3,065,649 (New Position) | Filing History |
| 2025-02-12 3:53 pm Sale | 2024-12-31 | 13G | MOLECULAR TEMPLATES INC NE MTEM | SilverArc Capital Management, LLC | 0 0.000% | -354,608 (Position Closed) | Filing History |
| 2025-02-12 3:44 pm Purchase | 2024-12-31 | 13G | ELUTIA INC ELUT | SilverArc Capital Management, LLC | 1,782,271 5.900% | 136,463 (+8.29%) | Filing History |
| 2024-10-15 06:59 am Purchase | 2024-10-11 | 13G | ELUTIA INC ELUT | SilverArc Capital Management, LLC | 1,645,808 5.530% | 1,645,808 (New Position) | Filing History |